SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
3.8 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
98853 |
2160 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
4.1 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
98854 |
2160 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
4.0 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98855 |
2160 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
72 days
| 5 |
4.1 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99349 |
2278 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
4.1 |
mm |
0.4 |
0.98 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
720 |
min |
98852 |
2160 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
3.8 |
mm |
0.4 |
0.98 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
360 |
min |
98850 |
2160 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
72 days
| 5 |
4.0 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
ACF |
2 |
days |
99350 |
2278 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 8 |
5.9 |
mm |
0.2 |
0.57 |
echocardiography |
0.0 |
ACF |
28 |
days |
99354 |
2278 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 8 |
6.8 |
mm |
0.3 |
0.85 |
echocardiography |
0.0 |
ACF |
28 |
days |
99352 |
2278 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
4.1 |
mm |
0.5 |
1.22 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
5 |
days |
98856 |
2160 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 8 |
6.3 |
mm |
0.3 |
0.85 |
echocardiography |
0.0 |
ACF |
28 |
days |
99240 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 8 |
4.3 |
mm |
0.3 |
0.85 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99239 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 7 |
4.7 |
mm |
0.2 |
0.53 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99353 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
4.2 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
98851 |
2160 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
175 days
| 10 |
5.6 |
mm |
0.1 |
0.32 |
echocardiography |
0.0 |
sham ACF |
105 |
days |
99241 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
98 days
| 7 |
4.7 |
mm |
0.2 |
0.53 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99351 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-systolic diameter |
male |
0 days
| 6 |
3.9 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
98857 |
2160 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
175 days
| 10 |
7.4 |
mm |
0.3 |
0.95 |
echocardiography |
0.0 |
ACF |
105 |
days |
99242 |
2278 |
SD |
heart left ventricle end-systolic diameter |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
72 days
| 5 |
4.3 |
mm |
0.5 |
1.12 |
echocardiography |
0.0 |
ACF |
2 |
days |
99348 |
2278 |
SD |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-systolic diameter |
male |
72 days
| 5 |
4.0 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99347 |
2278 |